Zacks Investment Management Horizon Therapeutics Public LTD CO Transaction History

Zacks Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$96.34 - $112.38 $1,734 - $2,022	18 Added 0.12%	14,940 $1.54 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $1,734 - $2,022	-18 Reduced 0.12%	14,922 $1.53 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $1,073 - $1,135	-10 Reduced 0.07%	14,940 $1.63 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $79,235 - $144,526	-1,270 Reduced 7.83%	14,950 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.29 Million - $1.89 Million	16,220 New	16,220 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1.02 Million - $1.28 Million	-15,151 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $836,789 - $1.21 Million	15,151 New	15,151 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $1.3 Million - $1.59 Million	-56,696 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $1.29 Million - $1.61 Million	56,696 New	56,696 $1.36 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.